Jiangsu GDK Biotechnology Co Ltd (688670) — Working Capital to Net Assets Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Working Capital to Net Assets ratio of 9.8% as of March 2026. Working capital of CN¥105.62 Million (current assets of CN¥307.64 Million minus current liabilities of CN¥202.02 Million) is measured against net assets of CN¥1.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jiangsu GDK Biotechnology Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu GDK Biotechnology Co Ltd Working Capital to Net Assets (2017–2025)
This chart shows how Jiangsu GDK Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 9.8%, reflecting working capital of CN¥105.62 Million against net assets of CN¥1.08 Billion CNY. For the complete balance sheet picture, see Jiangsu GDK Biotechnology Co Ltd balance sheet assets.
Annual Working Capital to Net Assets for Jiangsu GDK Biotechnology Co Ltd (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 688670 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.4% | CN¥114.00 Million | CN¥1.10 Billion | CN¥355.66 Million | CN¥241.66 Million | ▼ -18.7 pp |
| 2024 | 29.1% | CN¥371.70 Million | CN¥1.28 Billion | CN¥582.58 Million | CN¥210.88 Million | ▼ -7.0 pp |
| 2023 | 36.1% | CN¥494.91 Million | CN¥1.37 Billion | CN¥722.24 Million | CN¥227.34 Million | ▼ -8.3 pp |
| 2022 | 44.4% | CN¥648.52 Million | CN¥1.46 Billion | CN¥951.02 Million | CN¥302.50 Million | ▼ -13.6 pp |
| 2021 | 58.0% | CN¥848.02 Million | CN¥1.46 Billion | CN¥1.07 Billion | CN¥221.68 Million | ▲ +52.4 pp |
| 2020 | 5.7% | CN¥13.71 Million | CN¥242.50 Million | CN¥522.79 Million | CN¥509.07 Million | ▼ -357.2 pp |
| 2019 | 362.8% | CN¥-393.22 Million | CN¥-108.38 Million | CN¥95.34 Million | CN¥488.56 Million | ▼ -51.0 pp |
| 2018 | 413.8% | CN¥-369.71 Million | CN¥-89.34 Million | CN¥13.17 Million | CN¥382.88 Million | ▼ -120.3 pp |
| 2017 | 534.1% | CN¥-327.57 Million | CN¥-61.33 Million | CN¥13.25 Million | CN¥340.82 Million | — |